About Envista Holdings Corp
Ticker
info
NVST
Trading on
info
NYSE
ISIN
info
US29415F1049
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Paul A. Keel
Headquarters
info
Building E, Brea, CA, United States, 92821-6208
Employees
info
12,000
Website
info
https://envistaco.com
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Metrics
BasicAdvanced
Market cap
info
$4.39B
P/E ratio
info
95.36
EPS
info
$0.28
Dividend Yield
info
0.00%
Beta
info
0.95
Forward P/E ratio
info
21.69
EBIDTA
info
$362M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.39B
Average daily volume
info
2.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
95.36
Forward P/E
info
21.69
PEG ratio
info
-
Trailing P/E
info
95.36
Price to sales
info
1.61
Price to book
info
1.41
Earnings
EPS
info
$0.28
EPS estimate (current quarter)
info
$0.32
EPS estimate (next quarter)
info
$0.28
EBITDA
info
$362M
Revenues (TTM)
info
$2.72B
Revenues per share (TTM)
info
$16.19
Technicals
Beta
info
0.95
52-week High
info
$30.42
52-week Low
info
$14.22
50-day moving average
info
$25.69
200-day moving average
info
$21.52
Short ratio
info
2.17
Short %
info
5.44%
Management effectiveness
ROE (TTM)
info
1.56%
ROA (TTM)
info
2.78%
Profit margin
info
1.73%
Gross profit margin
info
$1.5B
Operating margin
info
10.74%
Growth
Quarterly earnings growth (YoY)
info
3,146.10%
Quarterly revenue growth (YoY)
info
15.00%
Share stats
Outstanding Shares
info
164M
Float
info
163M
Insiders %
info
0.56%
Institutions %
info
113.17%
Analyst Insights & forecasts
info

22% Buy

71% Hold

7% Sell

Based on information from 14 analysts.

Average price target

info
$28.46
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.24
$0.20
20.00%
Q1 • 25Beat
$0.26
$0.23
13.04%
Q2 • 25Beat
$0.32
$0.28
14.29%
Q3 • 25Beat
$0.38
$0.32
18.75%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$670M
$-30.3M
-4.52%
Q3 • 25
$751M
$32.9M
4.38%
Q4 • 25
12.05%
-208.58%
-196.91%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$5.64B
$2.55B
45.27%
Q3 • 25
$5.68B
$2.57B
45.30%
Q4 • 25
0.65%
0.72%
0.07%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$78.7M
$-9.7M
$-41.7M
$67.9M
Q3 • 25
$108M
$0.2M
$-25.2M
$91.7M
Q4 • 25
37.23%
-102.06%
-39.57%
35.05%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Envista Holdings Corp share?
Collapse

Envista Holdings Corp shares are currently traded for undefined per share.

How many shares does Envista Holdings Corp have?
Collapse

Envista Holdings Corp currently has 164M shares.

Does Envista Holdings Corp pay dividends?
Collapse

No, Envista Holdings Corp doesn't pay dividends.

What is Envista Holdings Corp 52 week high?
Collapse

Envista Holdings Corp 52 week high is $30.42.

What is Envista Holdings Corp 52 week low?
Collapse

Envista Holdings Corp 52 week low is $14.22.

What is the 200-day moving average of Envista Holdings Corp?
Collapse

Envista Holdings Corp 200-day moving average is $21.52.

Who is Envista Holdings Corp CEO?
Collapse

The CEO of Envista Holdings Corp is Paul A. Keel.

How many employees Envista Holdings Corp has?
Collapse

Envista Holdings Corp has 12,000 employees.

What is the market cap of Envista Holdings Corp?
Collapse

The market cap of Envista Holdings Corp is $4.39B.

What is the P/E of Envista Holdings Corp?
Collapse

The current P/E of Envista Holdings Corp is 95.36.

What is the EPS of Envista Holdings Corp?
Collapse

The EPS of Envista Holdings Corp is $0.28.

What is the PEG Ratio of Envista Holdings Corp?
Collapse

The PEG Ratio of Envista Holdings Corp is null.

What do analysts say about Envista Holdings Corp?
Collapse

According to the analysts Envista Holdings Corp is considered a hold.